Roche Holding AG, more popularly known as Roche, is currently developing an experimental drug which targets to treat Alzheimer’s Disease among the elderly. According to the Swiss drugmaker on Sunday, this certain drug is targeted to remove the amyloid plaques in the brains of patients with Alzheimer’s Disease of an early stage. Most researchers and Related posts: Alzheimer’s Disease—A Result of Infection?
See the rest here:
Alzheimer’s Drug on the Works for Roche


John


